1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one has been researched along with Angiogenesis, Pathologic in 1 studies
1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one: structure given in first source; inhibits guanylyl cyclase
1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one : A member of the class of oxadiazoloquinoxalines that is 1H-[1,2,4]oxadiazolo[4,3-a]quinoxaline substituted at position 1 by an oxo group.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kawasaki, K | 1 |
Smith, RS | 1 |
Hsieh, CM | 1 |
Sun, J | 1 |
Chao, J | 1 |
Liao, JK | 1 |
1 other study available for 1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one and Angiogenesis, Pathologic
Article | Year |
---|---|
Activation of the phosphatidylinositol 3-kinase/protein kinase Akt pathway mediates nitric oxide-induced endothelial cell migration and angiogenesis.
Topics: Adenoviridae; Animals; Blotting, Western; Capillaries; Cell Adhesion; Cell Division; Cell Movement; | 2003 |